menu search

Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™

Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™
First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroups Noninvasive imaging and biomarker data support findings on liver biopsy and demonstrate broad treatment response to resmetirom Further analyses of results reinforce resmetirom safety and tolerability profile Company to host an investor event and webcast on Saturday, June 24 […] The post Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Op... Read More
Posted: Jun 22 2023, 07:30
Author Name: forextv
Views: 112526

Search within

Pages Search Results: